Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 34251-34300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06095492
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
NARecruiting
200 participants
Started: Oct 30, 2023 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT06399666
Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation
N/ARecruiting
182 participants
Started: Oct 30, 2023 · Completed: Feb 28, 2026
3 conditions2 sponsors2 locations
NCT06078254
Senstivity and Specificity of Lung Ultrasound for Early Detection of ARDS in Patients With Chest Trauma
N/ARecruiting
30 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06477991
The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.
N/ARecruiting
22 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT06125041
Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC
PHASE2Recruiting
51 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06125080
The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) :Single-arm, Prospective, Open Clinical Study
PHASE2Recruiting
78 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT05827536
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
NARecruiting
20 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05918211
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
PHASE3Recruiting
436 participants
Started: Oct 30, 2023 · Completed: Oct 28, 2025
1 condition1 sponsor40 locations
NCT06257043
"Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in Real World Chinese Patients"
N/ARecruiting
3,000 participants
Started: Oct 30, 2023 · Completed: Jan 1, 2034
1 condition1 sponsor1 location
NCT06098560
Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients
N/ARecruiting
60 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06078150
Effects of Active Video Games on Chinese Overweight and Obese College Students' Physical and Mental Health
NARecruiting
58 participants
Started: Oct 30, 2023 · Completed: Feb 15, 2024
3 conditions1 sponsor1 location
NCT06316076
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
PHASE1Recruiting
48 participants
Started: Oct 30, 2023 · Completed: Jun 30, 2026
4 conditions2 sponsors1 location
NCT05953090
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
NARecruiting
2,000 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2026
6 conditions1 sponsor12 locations
NCT05949606
A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
PHASE1/PHASE2Recruiting
160 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06109870
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
NARecruiting
920 participants
Started: Oct 30, 2023 · Completed: Aug 31, 2030
1 condition1 sponsor2 locations
NCT05550155
Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations
NARecruiting
120 participants
Started: Oct 30, 2023 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT06145009
Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women
NARecruiting
36 participants
Started: Oct 30, 2023 · Completed: Dec 20, 2024
4 conditions1 sponsor1 location
NCT06092645
Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma
PHASE2Recruiting
48 participants
Started: Oct 30, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06112730
Nutritional Supplementation in Patients With Chronic Respiratory Disease
NARecruiting
120 participants
Started: Oct 30, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT06613932
Assessment of L-PRF, Nanohydroxyapatite Combined With L-PRF Using Pulpotomy in Mature Mandibular First Molars
NARecruiting
45 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2024
1 condition1 sponsor1 location
NCT05694572
Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices
N/ARecruiting
2,500 participants
Started: Oct 30, 2023 · Completed: Jun 15, 2031
3 conditions1 sponsor1 location
NCT06060392
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
NARecruiting
50 participants
Started: Oct 30, 2023 · Completed: Nov 1, 2025
2 conditions1 sponsor1 location
NCT05925881
Lower Trapezius Transfer vs Bridging Reconstruction
NARecruiting
60 participants
Started: Oct 30, 2023 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT05320666
An Evaluation of the Yes You Can... Make Smart Choices Curriculum
NARecruiting
2,600 participants
Started: Oct 30, 2023 · Completed: Mar 15, 2026
2 conditions2 sponsors13 locations
NCT05976971
Microstructural and Sodium 7 Tesla Brain MRI in Idiopathic REM Sleep Behaviour Disorder
NARecruiting
32 participants
Started: Oct 30, 2023 · Completed: Oct 30, 2025
1 condition2 sponsors1 location
NCT06114407
Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib
PHASE2Recruiting
184 participants
Started: Oct 30, 2023 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT06025448
Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?
NARecruiting
20 participants
Started: Oct 30, 2023 · Completed: Mar 1, 2033
2 conditions1 sponsor1 location
NCT06116227
Whole-Body Vibration Training On Thermal Burn Injury In Pediatrics
NARecruiting
60 participants
Started: Oct 30, 2023 · Completed: Aug 15, 2024
1 condition1 sponsor1 location
NCT06110377
MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine)
PHASE4Recruiting
60 participants
Started: Oct 30, 2023 · Completed: Apr 2, 2025
1 condition1 sponsor1 location
NCT05999188
Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC)
N/ARecruiting
100 participants
Started: Oct 30, 2023 · Completed: Dec 12, 2030
1 condition5 sponsors1 location
NCT06190067
Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
PHASE2Recruiting
40 participants
Started: Oct 30, 2023 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT05994534
PK and PD Study of NPI-001 and Cysteamine Bitartrate
PHASE1/PHASE2Recruiting
12 participants
Started: Oct 29, 2023 · Completed: Jun 21, 2025
1 condition1 sponsor1 location
NCT06125847
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
EARLY_PHASE1Recruiting
12 participants
Started: Oct 29, 2023 · Completed: Nov 30, 2028
1 condition1 sponsor1 location
NCT06127641
Rehabilitation of People With Post-tuberculosis Lung Disease
NARecruiting
40 participants
Started: Oct 28, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT06032884
IHD Versus CRRT for Severe Acute Kidney Injury in Critically Ill Patients
NARecruiting
1,000 participants
Started: Oct 28, 2023 · Completed: Jan 28, 2026
1 condition1 sponsor1 location
NCT06219590
Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy
NARecruiting
80 participants
Started: Oct 28, 2023 · Completed: Jan 30, 2024
2 conditions1 sponsor1 location
NCT06648551
Diagnostic Performance of Controlling Nutritional Status as a Nutritional Screening Tool in Patients With Inflammatory Bowel Disease
N/ARecruiting
60 participants
Started: Oct 28, 2023 · Completed: Oct 28, 2027
1 condition1 sponsor1 location
NCT06189092
Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study
N/ARecruiting
65 participants
Started: Oct 28, 2023 · Completed: Nov 28, 2027
1 condition1 sponsor1 location
NCT05794542
Cue X as a Treatment for People With Parkinson's Disease
NARecruiting
30 participants
Started: Oct 28, 2023 · Completed: May 1, 2024
1 condition1 sponsor1 location
NCT06035549
Resilience in East Asian Immigrants for Advance Care Planning Discussions
NARecruiting
54 participants
Started: Oct 27, 2023 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06105151
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
PHASE1Recruiting
82 participants
Started: Oct 27, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05978284
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
PHASE1/PHASE2Recruiting
54 participants
Started: Oct 27, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05980000
Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell Carcinoma
PHASE2Recruiting
72 participants
Started: Oct 27, 2023 · Completed: Apr 30, 2031
6 conditions2 sponsors1 location
NCT06083012
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
N/ARecruiting
150 participants
Started: Oct 27, 2023 · Completed: Apr 27, 2027
3 conditions2 sponsors7 locations
NCT06039176
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
N/ARecruiting
150 participants
Started: Oct 27, 2023 · Completed: Dec 25, 2026
8 conditions11 sponsors8 locations
NCT05743595
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
PHASE1Recruiting
12 participants
Started: Oct 27, 2023 · Completed: Jan 31, 2030
1 condition4 sponsors1 location
NCT04276116
"Effectiveness of the Evaluation and Communication of Pulmonary Age as Help for Smoking Cessation"
NARecruiting
800 participants
Started: Oct 27, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06123104
Assessment of Automatic Tourniquets for Soldiers During Wartime
NARecruiting
10 participants
Started: Oct 27, 2023 · Completed: Dec 30, 2024
2 conditions1 sponsor1 location
NCT06304753
ContriBution of Digital RemOte MoniToring to IMPROVing The Effectiveness of Treatment in Patients With Chronic Heart Failure With Low Ejection Fraction
NARecruiting
60 participants
Started: Oct 27, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor2 locations
NCT06032104
Feasibility and Colorectal Benefits of Pulses Supplementation
NARecruiting
25 participants
Started: Oct 27, 2023 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location